M312 a case for oral challenge in patients with high peanut sensitivity to guide treatment decisions

Peanut allergy prevalence is increasing in the United States; it is a persistent allergy and common etiology of fatal and near-fatal anaphylaxis. Oral immunotherapy (OIT) is increasingly available to desensitize peanut-allergic children but optimal patient selection remains unknown.
Source: Annals of Allergy, Asthma and Immunology - Category: Allergy & Immunology Authors: Source Type: research